¿¬¼ö°­ÁÂ
International Society for Molecular Neurodegeneration (ISMND) 2024 Conference ¹× 2024³â Á¦16ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ DAY3 : 2024-05-29

International Society for Molecular Neurodegeneration (ISMND) 2024 Conference ¹× 2024³â Á¦16ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ DAY3 : 2024-05-29
±³À°ÀÏÀÚ : 2024-05-29
±³À°Àå¼Ò : ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£

±³À°ÁÖÁ¦ : International Society for Molecular Neurodegeneration (ISMND) 2024 Conference ¹× 2024³â Á¦16ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ DAY3

ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ  
´ã´çÀÚ : µµÀμ÷
¿¬¶ôó : 02-6677-0534

À̸ÞÀÏ : office@ismnd2024.org

±³À°Á¾·ù : ½Å°æ°ú

Âü¼®¿¹»óÀÎ : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 950,000¿ø  

ºñ°í ISMND ȸ¿ø - Professional: 600,000¿ø / Postdocs/Fellows/Residents: 300,000¿ø / Students: 100,000¿øISMND ºñȸ¿ø - Professional: 950,000¿ø / Postdocs/Fellows/Residents: 450,000¿ø / Students: 250,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 08:30~08:45 Role of necroptosis in neuronal death and neurodegeneration Xiaodong Wang(National Institute of Biological Sciences)

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 08:45~09:00 Role of TDP-43 splicing repression in Alzheimer's disease exhibiting co-pathology of TDP-43 Philip Wong(Johns Hopkins University)

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 09:00~09:15 Aggregation/spreading of RNA binding proteins in ALS pathogenesis Sandrine Da Cruz(KU Leuven)

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 09:15~09:30 Examining the therapeutic potential of microglial transplantation in chimeric models of AD and FTD Mathew Blurton-Jones(UC Irvine)

Åä·Ð 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 09:30~09:50 Q&As ()

ÈÞ½Ä 05¿ù 29ÀÏ ÄÁÆÛ·±½º·ë(³²) 4Ãþ ·Îºñ ¹× 402È£ 09:50~10:10 Coffee Break / Exhibits ()

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 10:10~10:25 Early events leading to neuronal dysfunction and neurodegeneration in glaucoma Adriana Di Polo(University of Montreal)

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 10:25~10:40 The forefront of fight for vision: In vivo genome editing for retinal degeneration ±èÁ¤ÈÆ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 10:40~10:55 Ocular imaging and artificial intelligence-based approach to study eye diseases Carol Cheung(Chinese University of Hong Kong)

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 10:55~11:10 Neuronal regulation of microglia homeostasis in development and disease Melanie Samuel(Baylor College of Medicine)

Åä·Ð 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 11:10~11:30 Q&As ()

½Ä»ç 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 12:00~13:00 Lunch Break ()

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 13:00~13:20 Successes, challenges, and future directions in Alzheimer¡¯s disease ¹Ú±âÇü(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 13:20~13:40 Exploring lymphatic routes for brain clearance °í±Ô¿µ(Çѱ¹°úÇбâ¼ú¿ø)

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 13:40~14:00 Can synaptic loss in Alzheimer ¼ºÀ翵(°í·ÁÀÇ´ë)

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 14:00~14:20 Discovery of potent and selective Keap1/Nrf2 modulators for the treatment of Alzheimer¡¯s disease ¹Ú±â´ö(Çѱ¹°úÇбâ¼ú¿¬±¸¿ø)

ÈÞ½Ä 05¿ù 29ÀÏ ÄÁÆÛ·±½º·ë(³²) 4Ãþ ·Îºñ ¹× 402È£ 14:20~14:35 Coffee Break / Exhibits ()

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 14:35~14:55 Crosstalk between neuroinflammation and synucleinopathy in Parkinson ±è¿µÀº(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 14:55~15:15 Tau aggregation and novel treatment approaches in movement disorders ±èÀ±°æ(Çѱ¹°úÇбâ¼ú¿¬±¸¿ø)

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 15:15~15:35 The role of mitochondrial genetics in the clinical management and therapeutic approaches of Parkinson's Disease Á¶¼º¾ç(¿ï»êÀÇ´ë)

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 15:35~15:55 Role of Reactive Astrocytes on Neurodegeneration in ¥á-Synucleinopathy °¨ÅÂÀÎ(Çѱ¹°úÇбâ¼ú¿ø)

ÈÞ½Ä 05¿ù 29ÀÏ ÄÁÆÛ·±½º·ë(³²) 4Ãþ ·Îºñ ¹× 402È£ 15:55~16:10 Coffee Break / Exhibits ()

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 16:10~16:40 Lost in local translation: TDP-43 and FUS in axonal/neuromuscular junction maintenance and dysregulation in ALS Sandrine Da Cruz(KU Leuven)

±³À°½Ã°£ 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 16:40~17:10 TDP-43 dependent cryptic exon: functional fluid biomarker and target validation Philip Wong(Johns Hopkins University)

Åä·Ð 05¿ù 29ÀÏ ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 17:10~17:30 Q&As ()

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[ºÎ»ê] 2024 ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ Áú°ü¸® ½ÉÆ÷Áö¿ò : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ BPEX 5Ãþ ÄÁÆÛ·±½ºÈ¦ ±³À°ÁÖÁ¦ : 2024 ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ Áú°ü¸® ½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : ´ëÇÑ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 894 , ´ñ±Û¼ö : 0

[ºÎ»ê] ´ëÇÑ°ñÀýÇÐȸ Á¦50Â÷ Çмú´ëȸ(1ÀÏÂ÷) : 2024-04-26

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ ºÎ»ê ±³À°ÁÖÁ¦ : ´ëÇÑ°ñÀýÇÐȸ Á¦50Â÷ Çмú´ëȸ(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑ°ñÀýÇÐȸ ´ã´çÀÚ : Á¤À¯Áø ¿¬¶ôó : 031-551

Ãßõ¼ö : 0 , Á¶È¸¼ö : 686 , ´ñ±Û¼ö : 0

[±¤ÁÖ] ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦42Â÷ Ãá°èÇмú´ëȸ_2nd day : 2024-04-26

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ±¤ÁÖ ±è´ëÁß ÄÁº¥¼Ç ¼¾ÅÍ ÄÁº£¼Ç Ȧ ¿Ü 8°÷ ±³À°ÁÖÁ¦ : ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦42Â÷ Ãá°èÇмú´ëȸ_2nd dayÁÖÃÖ±â°ü : ´ëÇѽŰæ¿Ü°ú

Ãßõ¼ö : 0 , Á¶È¸¼ö : 656 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ) Á¦9ȸ ºñ¸¸Àü¹®°¡ ±âÃÊ°úÁ¤ : 2024-04-28

±³À°ÀÏÀÚ : 2024-04-28 ±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦9ȸ ºñ¸¸Àü¹®°¡ ±âÃÊ°úÁ¤ ÁÖÃÖ±â°ü : ´ëÇѺñ¸¸ÇÐȸ ´ã´çÀÚ : ÃÖÀ±Áö ¿¬¶ôó : 02-6941-087

Ãßõ¼ö : 0 , Á¶È¸¼ö : 775 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇѳ»ºÐºñÇÐȸ SICEM 2024(1ÀÏÂ÷) : 2024-04-11

±³À°ÀÏÀÚ : 2024-04-11 ±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼­¿ï ±³À°ÁÖÁ¦ : SICEM 2024(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ ´ã´çÀÚ : ¹Ú¼öºó ¿¬¶ôó : 02-2038-0

Ãßõ¼ö : 0 , Á¶È¸¼ö : 822 , ´ñ±Û¼ö : 0